FUGL–MEYER ASSESSMENT (FMA)
A Comprehensive Clinical Guide for Physiotherapists
1. Introduction and Clinical Importance
Precise measurement of motor impairment is essential in neurological rehabilitation, particularly following stroke. While functional scales describe what a patient can do, impairment-level measures are required to understand neurological recovery versus compensation, guide intervention selection, and evaluate neuroplastic change.
The Fugl–Meyer Assessment (FMA) is one of the most extensively validated and widely used stroke-specific impairment assessment tools. It is grounded in neurophysiological principles of motor recovery and is considered the gold standard for measuring post-stroke motor impairment in both clinical practice and research.
Within a physiotherapy intranet and training ecosystem, the FMA should be positioned as an advanced, competency-based assessment tool, particularly for neurorehabilitation specialists, stroke units, and research-oriented clinicians.
2. Purpose of the Fugl–Meyer Assessment
The FMA is designed to:
• Quantify motor impairment severity after stroke
• Track sensorimotor recovery over time
• Differentiate true neurological recovery from compensation
• Guide task-specific and impairment-focused interventions
• Provide standardized data for research and outcome benchmarking
The FMA is not a functional independence scale; it evaluates body structure and function domains within the ICF framework.
3. Theoretical Basis
The FMA is based on Brunnstrom’s stages of motor recovery, reflecting the hierarchical progression of motor control after stroke:
• Flaccidity
• Emergence of synergistic movement
• Voluntary control within synergy
• Movement combining synergies
• Movement out of synergy
• Near-normal motor control
This theoretical grounding allows the FMA to capture qualitative aspects of motor recovery, not merely strength or task completion.
4. Constructs Measured
The full Fugl–Meyer Assessment evaluates five domains:
- Motor function (upper and lower extremity)
- Sensory function
- Balance
- Joint range of motion (ROM)
- Joint pain
In routine physiotherapy practice, the motor domain is most commonly used.
5. Indications and Patient Populations
The FMA is appropriate for:
• Acute, subacute, and chronic stroke
• Ischemic and hemorrhagic stroke
• Inpatient, outpatient, and community neurorehabilitation
• Research and clinical trials in stroke recovery
It is less suitable for:
• Non-stroke neurological conditions
• Very severe cognitive or communication impairment
• Rapid screening contexts (due to administration time)
6. Structure and Scoring Overview
Total Score Breakdown
• Motor domain: 100 points
– Upper extremity: 66
– Lower extremity: 34
• Sensory: 24 points
• Balance: 14 points
• Joint ROM: 44 points
• Joint pain: 44 points
Maximum total score: 226 points
Each item is scored on a 3-point ordinal scale:
• 0 = Cannot perform
• 1 = Performs partially
• 2 = Performs fully
Higher scores indicate less impairment.
7. Equipment and Test Setup
Equipment Required
• Examination plinth or bed
• Chair without armrests
• Reflex hammer (optional)
• Stopwatch
• Small objects (ball, pencil)
Environment
• Quiet, well-lit clinical space
• Adequate room for sitting and standing balance tasks
Standardization is critical for inter-rater reliability.
8. Step-by-Step Administration Procedure
Step 1: Patient Preparation
• Explain the purpose and length of the assessment
• Ensure patient comfort and appropriate clothing
• Allow rest breaks to minimize fatigue
Step 2: Sequence of Testing
Follow the standardized order:
- Upper extremity motor items
- Lower extremity motor items
- Balance
- Sensation
- ROM and pain
Deviation from sequence can affect scoring consistency.
Step 3: Motor Assessment – Upper Extremity
Assess:
• Reflex activity
• Volitional movement within synergy
• Volitional movement mixing synergies
• Volitional movement out of synergy
• Wrist and hand function
• Coordination and speed
Score each item strictly according to criteria.
Step 4: Motor Assessment – Lower Extremity
Assess:
• Reflexes
• Hip, knee, and ankle movements
• Coordination during heel-to-shin task
Step 5: Balance Assessment
Includes:
• Sitting balance
• Standing balance
Observe postural control and safety.
Step 6: Sensory, ROM, and Pain
• Test light touch and proprioception
• Assess passive ROM
• Record pain during passive movement
9. Correct Scoring and Common Errors
Correct Practice
• Score observed performance only
• Do not coach beyond standard instructions
• Use the same examiner when possible
• Allow adequate rest to avoid fatigue-related underperformance
Common Errors
• Over-scoring partial movements
• Providing facilitation during testing
• Using functional success instead of movement quality
• Ignoring synergy patterns
10. Interpretation of FMA Scores
Motor Severity Classification (Upper Extremity)
• <20: Severe impairment
• 20–35: Moderate impairment
• >35: Mild impairment
Clinical Meaning
Higher scores reflect:
• Improved motor control
• Reduced synergy dominance
• Greater voluntary movement selectivity
11. Reliability of the FMA
Inter-Rater Reliability
• ICC values: 0.95–0.99 (motor domain)
Test–Retest Reliability
• ICC values: 0.96–0.98
These values indicate excellent reliability across acute and chronic stroke populations.
12. Validity of the FMA
Content Validity
• Strong theoretical alignment with motor recovery stages
Construct Validity
• Strong correlations with:
– Motor performance tests
– Functional measures such as ADL scales
Correlation coefficients commonly range from 0.70 to 0.90.
13. Responsiveness and MCID
Responsiveness
The FMA is highly responsive to:
• Task-specific training
• Constraint-induced movement therapy
• Robot-assisted therapy
• Intensive neurorehabilitation
Minimal Clinically Important Difference (MCID)
Reported MCID values:
• Upper extremity: ≈5–10 points
• Lower extremity: ≈4–7 points
Values vary depending on stroke phase and severity.
14. Clinical Decision-Making Using the FMA
FMA results guide:
• Selection of impairment-based vs task-based interventions
• Progression from synergy-based training to selective movement
• Goal setting aligned with neurological recovery
• Prognostication of upper limb recovery
Examples:
• Low FMA UE score → emphasize proximal control and synergy management
• Plateauing FMA with improving function → compensation likely
• Improving FMA → true neurological recovery occurring
15. SOAP-Based Documentation Example
S:
Patient reports difficulty controlling arm movements during reaching.
O:
FMA-UE: 28/66; synergy-dominated shoulder and elbow movement.
A:
Moderate upper limb motor impairment with limited selective control.
P:
Task-specific reaching with emphasis on out-of-synergy movement. Reassess FMA in 3 weeks.
16. Reassessment and Outcome Tracking
Recommended reassessment:
• Every 3–4 weeks in active neurorehabilitation
• At program milestones
• Pre-discharge
Due to its detail, the FMA is not recommended for daily reassessment.
17. Advantages and Limitations
Advantages
• Gold standard for post-stroke motor impairment
• Excellent reliability and validity
• Sensitive to neurological recovery
• Strong research applicability
Limitations
• Time-consuming (30–45 minutes)
• Requires training for accurate scoring
• Limited applicability outside stroke
18. Key Clinical Takeaways
• The FMA is the gold-standard impairment measure for stroke
• Based on neurophysiological recovery principles
• Demonstrates excellent reliability and validity
• MCID ranges from 5–10 points (UE)
• Essential for distinguishing recovery from compensation
19. Key Literature References
- Fugl-Meyer AR, Jääskö L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient: A method for evaluation of physical performance. Scandinavian Journal of Rehabilitation Medicine. 1975;7(1):13–31.
- Gladstone DJ, Danells CJ, Black SE. The Fugl-Meyer Assessment of motor recovery after stroke: A critical review of its measurement properties. Neurorehabilitation and Neural Repair. 2002;16(3):232–240.
- Platz T, Pinkowski C, van Wijck F, et al. Reliability and validity of arm function assessment with standardized guidelines for the Fugl–Meyer Test. Journal of Rehabilitation Medicine. 2005;37(4):241–248.
- Page SJ, Fulk GD, Boyne P. Clinically important differences for the upper-extremity Fugl-Meyer Scale in people with minimal to moderate impairment due to chronic stroke. Physical Therapy. 2012;92(6):791–798.
- Sullivan KJ, Tilson JK, Cen SY, et al. Fugl–Meyer Assessment of sensorimotor function after stroke: Standardized training procedure for clinical practice and research. Stroke. 2011;42(2):427–432.